Embed Size (px)
DESCRIPTION
Presentation given by Manuel Talon from Valencian Agricultural Research Institute (IVIA) in the framework of the Emergence Forum Barcelona Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation. More information at: http://www.b2match.eu/emergenceforum2014
Citation preview
Citriculture Innovations in
the Post-Genomic Era
Manuel Talon Instituto Valenciano de Investigaciones Agrarias
Valencia (Spain)
Characterization of genetic, genomic and metabolic
variability of citrus and its biotechnological applications
IPT-010000-2010-043
MAIN GOALS
GENERATION OF NEW CITRUS VARIETIES
BIOTECNOLOGIAL APPLICATIONS
www.citrusgenn.es
www.citrusgenn.es
GENERATION OF NEW CITRUS VARIETIES
HÍBRIDOS
50 cruzamientos
30.000 plantas
www.citrusgenn.es
GENERATION OF NEW CITRUS VARIETIES
www.citrusgenn.es
Variety identification and authentication
BIOTECHNOLOGICAL APPLICATIONS
BIOTECHNOLOGICAL APPLICATIONS
Molecular markers
CLEMENULES
CLEMENVERD
CLEMENULES CLEMENVERD
www.citrusgenn.es
1) MAIN INNOVATIONS
Implementation of breeding approaches through genomic selection.
The free availability of genomic information.
Variety authentication protocols.
www.citrusgenn.es
2) DERIVED PRODUCTS
6000 new lines of citrus.
Availability of citrus genomes
40,000 genes / millions of gene variants
Lineages and kinship
www.citrusgenn.es
3) ESTIMATED OPERATING RESULTS
Marketing of varieties of interest.
Listings of markers / authentication protocols
• illigal entries and orchards,
• clandestine nurseries,
• breeders disputes,
• theft and misappropriation,
• varietal demand planning,
• juice quality
Citriculture Innovations in the
Post-Genomic Era
